Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02266823 · ClinicalTrials.gov registry record · NA

Diabetes CKD Lifestyle Technology Study

A NA study of Obesity and Diabetes, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
270
Enrollment target
1
Study location

NCT02266823 is a NA study of Obesity and Diabetes that has completed, run by NYU Langone Health. The registered enrollment target is 270 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02266823, a NA study of Obesity and Diabetes, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
270 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to pilot test an mHealth technology-supported behavioral intervention designed to engage patients with diabetes and concurrent chronic kidney disease (CKD) in multiple behaviors which aim to reduce CKD progression. Participants will be randomized to the 6-month lifestyle intervention or to a wait-list control. The lifestyle intervention will be modeled after that used in the Diabetes Prevention Program (DPP) and the counseling intervention will be based on SCT, which will be paired with mobile technology-based dietary and physical activity monitoring. The wait-list control will receive 6 months of standard medical care followed by a delayed, but less intensive, 6-month intervention.

Interventions

  • BEHAVIORAL Social Cognitive Theory

Study Locations (1)

New York

  • NYU Langone Medical Center - New York

Trial Details

FieldValue
Enrollment Target 270 participants
Start Date 2015-10
Est. Completion 2019-11-08
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT02266823

The ClinicalTrials.gov registry entry for NCT02266823 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (67% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Social Cognitive Theory is the first listed.

NCT02266823 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02266823 about?

NCT02266823 is a clinical study titled "Diabetes CKD Lifestyle Technology Study". The purpose of this study is to pilot test an mHealth technology-supported behavioral intervention designed to engage patients with diabetes and concurrent chronic kidney disease (CKD) in multiple behaviors which aim to reduce CKD progression. Participants will be randomized to the 6-month lifestyle...

What is the current status of trial NCT02266823?

This trial is currently completed. It is a NA study. The enrollment target is 270 participants. The study started on 2015-10. Estimated completion is 2019-11-08.

What conditions does trial NCT02266823 study?

This clinical trial studies the following conditions: Obesity, Diabetes, Chronic Kidney Disease.

What interventions are being tested in trial NCT02266823?

The interventions under investigation include: Social Cognitive Theory (BEHAVIORAL).

Who is sponsoring clinical trial NCT02266823?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02266823 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.